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Overlapping Medication Associated with Healthcare Switching 
among Korean Elderly Diabetic Patients
This study was performed to describe the patterns of healthcare switching with overlapping 
use of anti-diabetic medication in the elderly using the Korea Health Insurance Review and 
Assessment Service’s claims data. The study subjects were ambulatory elderly diabetic 
patients (ICD-10, E10-14) receiving at least one oral anti-diabetic drug or insulin, and 
visiting healthcare facilities more than two times between January and December 2005. A 
total of 457,975 elderly diabetic ambulatory care patients were identified. The mean of 
visiting frequencies was 9.0 ( ± 3.6) and switching frequencies was 1.5 ( ± 0.8) during 
2005. Switching group consisted of 33% of total study subject. Healthcare switching was 
common in female patients who were older, and had treated polytherapy more in rural 
areas. The movement among primary care medical services was very common among the 
patients in the switching group (52.6%). A statistically significant correlation was observed 
between the healthcare switching and concomitant drug use (rho = 0.96), and overlapping 
days (rho = 0.57). The use of overlapping anti-diabetic medication increased with the 
extent of healthcare switching. Further, frequent switching of healthcare between primary 
clinics was observed. Efforts should be made to establish continuity for the elderly diabetic 
patients with the identification of frequent switching with overlapping medication. 
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INTRODUCTION
Korea is a rapidly aging society with persons over the age of 65 
accounting for 10.7% of the total population during mid 2010; 
population projections predict 14.3% by 2018 and 20.8% by 2026 
(1). Diabetes in the elderly has been reported as a growing prob-
lem; a larger proportion of newly diagnosed diabetics are older 
(2). Elderly diabetic patients need continuous monitoring for 
tight glycemic control and treatment with anti-diabetic drugs, 
for the prevention of diabetes related complications (3).
  Healthcare switching is referred to as the switching healthcare 
facilities without a professional referral in the same illness. It may 
contribute to the increased risk of overlapping medication among 
elderly patients (4, 5). With a culture that prefers taking medi-
cines and health supplements, in Asian countries, such behav-
iour had been a problem reported in several countries and is 
considered a serious public health concern (6, 7). In addition, 
patients do not need to register with a primary care physician, 
and they can visit any healthcare provider in Korea (8). Under 
the current health care delivery system, all of primary, second-
ary, tertiary hospital can provide ambulatory care. Under such 
circumstances, overlapping drug use associated with healthcare 
switching can result in serious health problems including poly-
pharmacy, higher cost, overlapping medication and adverse 
outcome such as acute hypoglycemia (9, 10); prescriptions might 
be duplicated without the knowledge of all healthcare provid-
ers (11). This can lead to drug-drug interactions and drug-dis-
ease interactions that can cause adverse drug events (12).
  However, limited information on the patterns of healthcare 
switching is known in the elderly diabetic patients. There has 
been no published epidemiologic study on overlapping drug 
use associated with switching healthcare institutions in a popu-
lation-based setting. Therefore, this study was performed to de-
scribe the patterns of healthcare utilization over one year and 
the association between the frequency of healthcare switching 
and overlapping use of anti-diabetic medication among the el-
derly diabetic patients. 
MATERIALS AND METHODS
Data source
The Korean Health Insurance Review and Assessment Service Shin J-Y, et al.  •  Overlapping Anti-diabetic Medication Associated with Healthcare Switching 
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(HIRA) database was used for this study. The National Health 
Insurance (NHI) program was initiated in Korea in 1977 and 
achieved universal coverage of the population by 1989 (13). All 
Koreans are covered by the National Health Insurance System. 
Accordingly, the HIRA database contains all information on 
healthcare utilization and prescribed medications for approxi-
mately 50 million Koreans.
  The claims data for elderly patients (aged 65 yr or older) that 
had been submitted by healthcare providers in 2005 were ob-
tained. The HIRA offered the claims data with the individual iden-
tity of patients concealed. The database included an unidentifi-
able code representing each individual together with age, gen-
der, diagnosis, and ambulatory care utilization at clinics and/or 
hospitals, dates of visits, types of medical care facilities, region 
and specialty. In addition, prescribed drug information includ-
ed the brand name, generic name, prescription date, duration 
and route of administration. The diagnosis was coded accord-
ing to the International Classification of Disease, Tenth Revision 
(ICD-10). The database contained information regarding 4,159,305 
elderly patients and 100,838,744 prescriptions.
 
Study subjects
We performed the population-based cross-sectional study. The 
study subjects were elderly diabetic patients older than 65 yr of 
age that presented to clinics and/or hospitals for ambulatory care 
from January 1, to December 31, 2005. A diabetic patient was de-
fined as a patient with a diagnosis consistent with ICD-10 (E10-
E14) and who had received prescriptions of insulin and/or oral 
anti-diabetic drugs (OAD). The OAD were selected on the treat-
ment guideline for diabetes (14, 15): sulfonylureas, metformin, 
meglitinides, thiazolidinedion, and alpha glucosidase inhibitors. 
Patients that presented to clinics and/or hospitals only one time 
in 2005 were excluded. 
Description of healthcare utilization patterns 
The healthcare utilization patterns of the ambulatory care visits 
are described as the visiting frequency (VF) and the switching 
frequency (SF) during the study period. The ‘VF’ was the total 
number of visit for the patient during 2005. The ‘SF’ was the num-
ber of times that the patient changed institutions; that is, how 
frequently the patient changed healthcare facilities during one 
year. The VF and SF referred to all ambulatory care visits for the 
oral anti-diabetic drugs. Healthcare utilization patterns are dis-
played in a cross-table that matches the VF and SF.
Definition of healthcare switching and non-switching group
The study population was divided into two groups: the non-
switching group and switching group. The non-switching group 
included patients who visited one healthcare facility regardless 
of the VF. The switching group included patients who changed 
medical institutions more than one time during the study peri-
od. Each group was compared including the patient character-
istics (age and gender) and healthcare provider’s characteristics 
(location and type of medical service: primary clinics, second-
ary hospital, and tertiary hospital). In addition, the frequency 
and proportion of the patients that had insulin therapy and/or 
OAD therapy, that is, mono- or polytherapy was calculated for 
each group. 
Institutional visiting patterns 
The institutional visiting patterns were determined by describ-
ing the movements from primary (P) to other primary clinics, or 
from primary to secondary (S) or tertiary facilities (T). Accord-
ing to the SF, the frequency of switching patterns for anti-dia-
betic medications in 2005 was determined. ‘P1→P2’ meant se-
quential movement from one primary clinic to another. ‘P1→ 
S1→P2’ meant that an elderly diabetic patient visited one pri-
mary clinic, moved to a secondary healthcare facility first, and 
then to other primary clinics during 2005. 
Assessment of overlapping anti-diabetic medication 
associated with healthcare switching 
Overlapping anti-diabetic medication was assessed as follows: 
total prescription days (TPD), total prescription days longer than 
365 days (TPD365), concomitant drug use (CDU), and overlap-
ping days (OD). The ‘TPD’ was defined as the total number of 
days of anti-diabetic prescriptions during 2005. The TPD was 
estimated using the “prescription duration” from the HIRA da-
tabase. The days for the diabetic prescription were added from 
the healthcare provider (one or more). The TPD365 was defined 
as the patient who was prescribed anti-diabetic medication lon-
ger than 365 days. 
  The ‘CDU’ was defined as a prescription from a different health-
care provider overlapping in duration the anti-diabetic medica-
tion (16). To assess the CDU, subjects were identified according 
to whether they had been prescribed a diabetic drug simultane-
ously from different healthcare providers. When the dates of the 
prescriptions overlapped, from different healthcare providers, 
it was considered a CDU. The starting date was recorded when 
the healthcare provider issued the prescription for the first course 
of anti-diabetic therapy. The end date of one anti-diabetic ther-
apy course was calculated using the information on the prescrip-
tion date and duration. 
  The ‘OD’ was defined as the number of days that anti-diabet-
ic drugs were duplicated from different healthcare providers. 
The OD was calculated by adding the days duplicated from the 
study subjects that had CDUs. According to the SF, mean num-
ber of TPD, the proportion of TPD356, the proportion of CDU, 
mean number of OD was calculated. 
Statistical analysis
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median, and range (min, max) are presented. The Cochran-Ar-
mitage test was used to identify statistically significant trends in 
age, region, type of medical service and drug therapy. To com-
pare the gender proportions, the chi-square test was used. As-
sociations between both healthcare switching and non-switch-
ing group and demographic factors and other indicators were 
quantified by adjusted odds ratios (ORs) and corresponding 
95% confidence intervals (CIs) using the multivariate logistic 
regression. 
  Spearman’s rank test was used for the SF to determine the cor-
relation with the each drug assessment indicator: TPD, TPD365, 
CDU, and OD. The significance level was set at P < 0.05 and all 
tests were two tailed. All data were analyzed using SAS 9.1 (SAS 
Institute Inc, Cary, NC, USA).
Ethics statement
The study protocol was approved by the institutional review 
board of the Seoul National University College of Medicine (IRB 
No. C-0908-048-292). Informed consent was waived by the 
board.
RESULTS
Study subjects 
A total of 457,975 elderly diabetic ambulatory care patients were 
identified from the HIRA database that had visited healthcare 
facilities and were coded with ICD-10 (E10-E14), and received 
more than one course of prescribed anti-diabetic medication. 
Their mean age (standard deviation [SD]) was 71.5 yr (± 5.3) and 
61.6% were female. 
Healthcare utilization patterns 
The median number of VF among Korean elderly diabetic pa-
tients was 10 with a mean of 9.0 (± 3.6) during 2005 (range 2-62). 
The median number of SF was one with a mean of 1.5 (± 0.8) 
during 2005 (range 1-17) (Fig. 1A). Fig. 1B shows the distribu-
tion of individuals receiving anti-diabetic prescriptions by the 
number of SF and VF. Most individuals (91.4%) used either one 
or two healthcare providers; 6.3% of individuals used two, 1.7% 
of individuals visited three different healthcare providers, and 
less than 1% used more than five providers. Overall, 191 (0.05%) 
individuals used six or more healthcare providers. 
Characteristics of healthcare switching group 
Among all Korean elderly diabetic patients who were prescribed 
more than one anti-diabetic medication, the healthcare switch-
ing group included 151,143 (33%), and the non-switching group 
306,832 (67%). The switching group consistently decreased 
among each successive age group (chi-square for trend, P <  
0.001). Comparison of the group aged 65 yr through 69, showed 
that an older age group was associated with healthcare switch-
ing (31.1% vs 30.0%; 18.3% vs 16.7%; 7.7% vs 6.9%; 2.1% vs 2.0%). 
In addition, female patients were significantly more likely to 
switching healthcare institutions than male patients (65.5% vs 
59.7%; ORadj, 1.26; 95% CI, 1.24-1.27) (Table 1).
  Of all prescriptions among the elderly diabetic patients, the 
visits in rural areas were associated with healthcare switching 
(23.1% vs 15.6%; ORadj, 1.43; 95% CI, 1.41-1.45). Relative to other 
types of medical service, visits to the primary medical clinic 
were associated with a significantly increased ratio of health-
care switching (69.6% vs 68.9%; ORadj, 1.90; 95% CI, 1.85-1.94). 
Anti-diabetic drug therapy was categorized as OAD mono, poly 
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Fig. 1. The distribution of individuals 
by the number of visiting frequency 
(VF), and switching frequency (SF) 
per year (A) The number of patients 
in 2005 was plotted as a function of 
the number of VF and SF. (B) Distri-
bution crosstable. Data are the VF 
and SF in 2005. (1A): Visiting fre-
quency (VF) among Korean elderly 
diabetic patients. Total N=457,975, 
median=10; mean = 9.0; starndard 
deviation = 3.6; range: 2-62. (2A): 
The switching frequency (SF) among 
Korean elderly diabetic patients. To-
tal N = 457,975, median = 1; mean 
= 1.5; starndard deviation = 0.8; 
range: 0-17. Shin J-Y, et al.  •  Overlapping Anti-diabetic Medication Associated with Healthcare Switching 
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or any insulin therapy; the proportion of patients that had any 
insulin therapy was high in the switching group (7.7% vs 5.2%; 
ORadj, 1.65; 95% CI, 1.63-1.72). Small medical service units, rural 
healthcare, an older age group, and the severity of diabetes were 
all associated with increased odds of healthcare switching in a 
linear trend (χ2 for trend, P < 0.001) (Table 1).
Switching patterns between institutions 
The ‘P1→P2’ type was the most common healthcare switching 
pattern among patients who changed one time (55.2%); ‘P1→ 
P2→P3’ was the most common pattern among patients who 
changed two times (47.1%); ‘‘P1→P2→P3→P4’ among patients 
that changed three times (42.1%), and ‘P1→P2→P3→P4→P5’ 
among patients that changed more than four times (38.8%). Al-
most half of the patients moved among primary medical ser-
vices in the switching group during 2005 (52.6%).
  The ‘P1→T1’ type was the second most frequent pattern con-
sisting of 15.8% of patients who changed once; ‘P1→P2→T1’ of 
patients who changed twice (10.7%); ‘P1→P2→P3→T1’ of pa-
tients who changed three times (7.7%), and ‘P1→P2→P3→P4→ 
T1’ of patients  who changed more than four times (4.8%). Health-
care switching among primary medical services and final move-
ment to a tertiary healthcare facility was commonly observed 
and was the second most common pattern (Table 2).
Trends in anti-diabetic medication use 
Fig. 2 shows the statistically significant correlation between the 
number of SF, and drug use assessment indicators: TPD, TPD365, 
CDU, and OD (Spearman’s rho = 0.99, P < 0.001; 0.92, P < 0.001; 
0.96, P < 0.001; 0.57, P = 0.04). 
  The mean number of TPD among elderly diabetic patients 
during 2005 increased rapidly from 264.9 days in the non-switch-
ing group to 275.4 days in three time switchers and 331.2 days 
in eight time switchers. The proportion of TPD365 was 7.4% 
Table 1. The characteristics of elderly diabetic patients in the healthcare switching group and non-switching group 
Parameters
Switching group Non-switching group 
OR (95% CI) P value* N = 151,143 (33.0%) N = 306,832 (67.0%)
N  % N  %
Age (yr), mean (SD)
   65-69
   70-74
   75-79
   80-84
   85 >=
        71.8 (5.3)
61,706 
47,000 
27,662 
11,591 
3,184 
 
40.8 
31.1 
18.3 
7.7 
2.1 
        71.4 (5.3)
136,415 
92,151 
51,080 
21,146 
6,040 
 
44.5 
30.0 
16.7 
6.9 
2.0 
 
Ref
1.11 (1.09-1.12)
1.17 (1.16-1.19)
1.18 (1.16-1.21)
1.14 (1.09-1.18)
 
     < 0.001
Gender
   Male
   Female
 
52,159 
98,984 
 
34.5 
65.5 
 
123,787 
183,045 
 
40.3 
59.7 
 
Ref
1.26 (1.24-1.27)
 
     < 0.001
†
Location
   Urban
‡
   Intermediate
   Rural
§
 
102,007 
48,875 
45,375 
 
52.0 
24.9 
23.1 
 
191,871 
67,236 
47,725 
 
62.5 
21.9 
15.6 
 
Ref
1.18 (1.16-1.19)
1.43 (1.41-1.45)
 
     < 0.001
Type of medical service
   Tertiary
   Secondary
   Primary
 
58,735
23,111
187,597
 
21.8
8.6
69.6
 
80,684 
14,907 
211,241 
 
26.3 
4.9 
68.9 
 
Ref
1.12 (1.10-1.13)
1.90 (1.85-1.94)
  < 0.001
   
Antidiabetic drug therapy
  Any OAD therapy
      Monotherapy
      Polytherapy
   Any insulin therapy
 
 
63,987 
75,457 
11,699 
 
 
42.3 
49.9 
7.7 
 
 
135,282 
155,566 
15,984 
 
 
44.1 
50.7 
5.2 
 
 
Ref
1.13 (1.02-1.16)
1.65 (1.63-1.72)
 
     < 0.001
*P value for trend was calculated by using Cochran-Armitage test; 
†P value was calculated by using chi-square test; 
‡Urban area included metropolitan cities and cities in the 
province that had a population of over 500,000; 
§Rural area included the towns that had a population of under 50,000. OAD, Oral Antidiabetic Drugs.
Table 2. Switching patterns between institutions among Korean elderly diabetic pa-
tients during 2005
Switching pattern description  No. %
1 time switcher (n = 109,937, 72.7%)
   P1→P2
   P1→T1
   T1→P1
   Others
 
60,638 
17,399 
14,489 
17,411 
 
55.2 
15.8 
13.2 
15.8 
2 time switcher (n = 30,433, 20.1%)
   P1→P2→P3
   P1→P2→T1
   P1→T1→P2
   Others
 
14,342 
3,255 
2,731 
10,105 
 
47.1 
10.7 
9.0 
33.2 
3 time switcher (n = 8,009, 5.3%)
   P1→P2→P3→P4
   P1→P2→P3→T1
   P1→P2→T1→P3
   Others
 
3,374 
618 
507 
3,510 
 
42.1 
7.7 
6.3 
43.8 
More than 4 time switcher (n = 2,764, 1.8%)
   P1→P2→P3→P4→P5
   P1→P2→P3→P4→T1
   P1→P2→T1→P3→P4
   Others
 
1,073
159 
137 
1,395 
 
38.8 
5.8 
5.0 
50.5 
P, Primary clinics; S, Secondary hospital; T, Tertiary hospital.Shin J-Y, et al.  •  Overlapping Anti-diabetic Medication Associated with Healthcare Switching 
http://jkms.org   1465 http://dx.doi.org/10.3346/jkms.2011.26.11.1461
among non-switching group, 11.1% for the one time switcher, 
15.7% for the four time switcher, 22.9% for the seven time switch-
er; it increased rapidly according to the SF. 
  The proportion of patients who had a CDU was 47% for the 
one time switchers, 69.6% for the two time switchers, 83.2 % for 
the three time switchers, and 90.5% for the four time switchers; 
it also increased dramatically according to an increase in the SF. 
Similarly, the OD was 6.2 days for one time switchers, 8.4 for two 
time switchers, 10.3 for six time switchers (Fig. 2). 
DISCUSSION
This study showed that the healthcare switching was not a com-
mon problem among elderly diabetic patients during one year. 
However, compared to the non-switching group, the switching 
group was more likely to be prescribed anti-diabetic drugs con-
comitantly. In addition, switching among primary medical in-
stitutions was very common; considering the very low propor-
tion of referral (17), this suggests that clinician referrals may be 
infrequent, self referral among patients is common reflecting 
inefficient healthcare delivery system in Korea. 
  In addition, the findings of this study showed that switching 
behavior occurred more frequently in female patients, older pa-
tients, rural areas, and included more severe diabetic patients. 
These findings are consistent with previous studies that report-
ed that the extent of healthcare switching was related to multi-
ple healthcare providers, low continuity of care, and was more 
common in older female patients (18). Gender differences are 
well known with regard to healthcare behavior as consistently 
shown by numerous reports from previous research (5, 12, 19). 
However, the findings of frequent switching behavior in severe 
diabetic patients, in rural areas had not been previously report-
ed. Severe diabetic patients were particularly vulnerable to ad-
verse events such as hypoglycemia or failure to maintain blood 
sugar levels. Therefore, the results suggest that prevention of in-
appropriate behavior in such populations is needed. It also sug-
gests where to target the frail population for the prevention of 
frequent healthcare switching and its associated risks. 
  Healthcare switching is a universal and dynamic process 
where each patient seeks a doctor for the optimum service and 
treatment. Further, it reflects a patient’s various concerns with 
regard to individual healthcare utilization (20). Additionally, di-
abetes care is complex as it involves both patient self-care and 
the administering of care by the provider (21). Healthcare switch-
ing in diabetic patients raises questions about the quality of the 
doctor-patient relationship. This may represent the absence of 
a stable relationship between patients and doctors, or dissatis-
faction with the heathcare as well as a result of a poor healthcare 
delivery system (22). Previous research reports that diabetic pa-
tients in early stages tend to move institutions in order to find 
their own doctor (23). However, our study results indicated that 
severe diabetic patients with a prescription of polytherapy tend-
ed to switch healthcare providers frequently. In terms of doctor-
patient relationships, they moved institutions for better service 
related to cost, kindness, patient participation, communication, 
or different therapeutic regimens (24, 25). There is also a possi-
bility that patients deliberately switch healthcare providers in 
order to obtain services they would not receive otherwise, such 
as overlapping or unnecessary medications (22). Such behavior 
has led to duplication of services, higher costs, and a risk of ad-
verse outcome such as acute hypoglycemia (12, 26, 27). 
  Of particular note, we observed one patient who had switched 
healthcare providers 17 times, and another 80% of patients who 
had switched more than three times all exhibited overlapping 
medication. From the perspective of patient safety and cost-con-
tainment, efforts should be made to study how continuity of 
care could be established to better address the needs of these 
patients. However, up to now, there has been little information 
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about the reasons some patients switch healthcare providers 
due to overlapping medication. Based on the data, not much 
can be done to help them. Ultimately, changes in the behavior 
of diabetic patients are needed to improve health care delivery 
through the introduction of a registered family physician sys-
tem (21). 
  Our study focused on describing their patterns including se-
quential changes and drug prescription patterns among insti-
tutions. With regard to drug use, the results showed that SF was 
highly correlated with the following drug exposure indicators: 
TPD, TPD365, CDU, and OD. Four drug exposures showed the 
increase according to the increase of extent of healthcare switch-
ing. The correlation coefficient might be near linear, and statis-
tically significant. This result shows that a substantial number 
of anti-diabetic drugs were prescribed without mutual recogni-
tion among the treating institutions; such patients could be ex-
posed to significant risks and adverse events, and the society 
subject to wasted medical resources. 
  In this study, healthcare visits were described as the distribu-
tion of individuals by SF and VF. According to the SF, the overlap-
ping of anti-diabetic medication could be described. The CDU 
was defined as overlapping of prescribing by different health-
care providers during the course of the medication; this provid-
ed an assessment of the differences in anti-diabetic drugs pre-
scribed among institutions. Previous research used measures 
such as ‘the number of drugs prescribed’ and ‘the number of 
days of medication’ based on the aggregate of the unit of service 
(12, 18, 22). In this study, the ‘CDU’ was used to represent both 
multiple providers and anti-diabetic drugs simultaneously. 
  In this study, prevalent cases were included; that is chronic 
and newly diagnosed, severe and mild patients. This had the 
advantage of reflecting real clinical practice. However, confound-
ing might be generated by the difference in the initial state when 
performing further study to evaluate the outcome. An approach 
to identify incident cases should be adopted in future research. 
For policy decisions, both descriptive and in-depth investiga-
tion should be performed together. 
  This study had several strengths. First, this study included a 
large population representing diabetic patients nationwide in 
Korea. An entire targeted population was studied rather than a 
sampled one using the claims database for ambulatory visits 
collected by the NHI program in Korea, which covers nearly all 
inhabitants of Korea. Second, a large national claims database 
was used to investigate the patient’s health related behavior. This 
database includes comprehensive information on more than 
50 million patients in Korea, and provides information on both 
the patient visit patterns and providers’ prescribing information. 
Third, it is the first nationwide epidemiological study regarding 
healthcare utilization among elderly diabetic patients to date. 
Both the healthcare visit pattern and it associated drug use were 
comprehensively investigated. The findings provided descriptive 
information about elderly diabetic patients’ healthcare switch-
ing and its associated overlapping use for anti-diabetic medica-
tion. Fourth, this study adopted the latest assessment methods 
for drug exposure to determine the extent of overlapping drug 
associated with healthcare switching. The results showed inap-
propriate drug use with overlapping prescriptions and suggests 
the risk of adverse outcome associated with healthcare switch-
ing behaviour (12, 26, 27).
  The limitations of this study include the following. First, refer-
rals could not be identified because the HIRA database did not 
include this information. Therefore, clinician referral and self-
referral may have been mixed in the switching group. However, 
previous research has reported a very low proportion of refer-
rals: the proportion of referral cases was only 0.7% of the total 
office visits in a Cheonan practice-based research network study 
composed of 10 clinics (17). Additionally, a few studies have re-
ported that there has been no change in healthcare utilization 
patterns after referral requirement were instituted for insurance 
patients on July 1, 1989 (28). Therefore, our research showed the 
sequential changing pattern between institutions, which has 
provided useful information about healthcare switching. How-
ever, to obtain more accurate results, information on referrals 
should be included in the database. Second, diabetic patients 
were defined according to the diagnosis reported to the HIRA, 
which might differ from the patients’ actual diagnosis. A valida-
tion study compared the diagnosis derived from the HIRA da-
tabase with the actual diagnosis in the patient medical records 
(29). The positive predictive value (PPV) was calculated accord-
ing to the disease group. The PPV was 72.3% for diabetes melli-
tus in the cases identified by ambulatory prescriptions.
  An online decision support system is planned to help prevent 
overlapping drug use and concurrent drug utilization review 
between institutions are in the process of being implemented 
in since December, 2010 (30). It will help avert contraindicated 
drug-drug interaction or overlapping drug use with the detec-
tion of healthcare switching behavior such as doctor-shopping. 
From the long-term perspective, an integrated healthcare de-
livery system, and an effective data exchange might be the solu-
tion for switching behaviour and the prevention for overlapping 
medication. 
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AUTHOR SUMMARY
Overlapping Medication Associated with Healthcare Switching among Korean 
Elderly Diabetic Patients
Ju-Young Shin, Nam-Kyong Choi, Sun-Young Jung, Ye-Jee Kim, Jong-Mi Seong and Byung-Joo Park
This study was performed to describe the patterns of healthcare switching with overlapping use of anti-diabetic medication in the 
elderly using the Korea Health Insurance Review and Assessment Service’s claims data. Healthcare switching was common in 
female patients that were older, and had treated polytherapy more in rural areas. A significant correlation was observed between 
healthcare switching and concomitant drug use, and overlapping days. Efforts should be made to establish continuity for the 
elderly diabetic patients with the identification of frequent switching with overlapping medication.